Stifel Reiterates Buy Rating on Zimmer Biomet (ZBH), 'we wait to more-thoughtfully reflect on these ERP-related challenges'
Tweet Send to a Friend
Stifel analyst Rick Wise reiterated a Buy rating and $130.00 price target on Zimmer Biomet (NYSE: ZBH).The analyst comments "This ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
